$NASDAQ:ILMN

BofA Cuts Illumina to Underperform Due to Growth Worries
Gallery

BofA Cuts Illumina to Underperform Due to Growth Worries

🌧️Trending News BofA recently downgraded Illumina ($NASDAQ:ILMN)'s stock to Underperform due to worries about its growth prospects. Illumina is a [...]

By GoodWhale|December 13, 2023|Categories: Diagnostics & Research, Profitability|Tags: $NASDAQ:ILMN, Diagnostics & Research, NASDAQ|0 Comments

Parties Express Interest in Illumina’s Grail Project: Report
Gallery

Parties Express Interest in Illumina’s Grail Project: Report

☀️Trending News According to a recent report, several parties have expressed interest in Illumina ($NASDAQ:ILMN)'s Grail project. Illumina is a [...]

By GoodWhale|November 29, 2023|Categories: Diagnostics & Research|Tags: $NASDAQ:ILMN, Diagnostics & Research, NASDAQ|0 Comments

ILLUMINA Reports USD 1119.0 Million in Revenue for FY2023 Q3, Up 0.4% Year-Over-Year
Gallery

ILLUMINA Reports USD 1119.0 Million in Revenue for FY2023 Q3, Up 0.4% Year-Over-Year

🌥️Earnings Overview For the third quarter of fiscal year 2023, which ended September 30 2023, Illumina ($NASDAQ:ILMN) reported total revenue [...]

By GoodWhale|November 20, 2023|Categories: Diagnostics & Research, Earnings Report, Profitability|Tags: $NASDAQ:ILMN, Diagnostics & Research, NASDAQ|0 Comments

Illumina Intrinsic Value – ILLUMINA Reports Record Earnings for Second Quarter of FY2023
Gallery

Illumina Intrinsic Value – ILLUMINA Reports Record Earnings for Second Quarter of FY2023

🌥️Earnings Overview ILLUMINA ($NASDAQ:ILMN) reported on June 30th 2023 that their total revenue for the second quarter of FY2023 was [...]

By GoodWhale|August 23, 2023|Categories: Diagnostics & Research, Earnings Report, Intrinsic Value|Tags: $NASDAQ:ILMN, Diagnostics & Research, NASDAQ|0 Comments

Illumina Intrinsic Value – ILLUMINA Reports 1.2% Increase in Revenue for Q2 2023.
Gallery

Illumina Intrinsic Value – ILLUMINA Reports 1.2% Increase in Revenue for Q2 2023.

☀️Earnings Overview Illumina ($NASDAQ:ILMN) announced their total revenue for the second quarter of FY2023 as USD 1176.0 million, a 1.2% [...]

By GoodWhale|August 14, 2023|Categories: Diagnostics & Research, Earnings Report, Intrinsic Value, Profitability|Tags: $NASDAQ:ILMN, Diagnostics & Research, NASDAQ|0 Comments

ILLUMINA Reports 1.2% YOY Increase in Revenue for Q2 2023
Gallery

ILLUMINA Reports 1.2% YOY Increase in Revenue for Q2 2023

☀️Earnings Overview On August 9 2023, Illumina ($NASDAQ:ILMN) reported total revenue of USD 1176.0 million for the quarter ending June [...]

By GoodWhale|August 13, 2023|Categories: Diagnostics & Research, Earnings Report, Profitability|Tags: $NASDAQ:ILMN, Diagnostics & Research, NASDAQ|0 Comments

Illumina Intrinsic Value Calculation – ILLUMINA Reports Strong Earnings for Q2 FY2023
Gallery

Illumina Intrinsic Value Calculation – ILLUMINA Reports Strong Earnings for Q2 FY2023

☀️Earnings Overview ILLUMINA ($NASDAQ:ILMN) reported their second quarter FY2023 earnings results on June 30, 2023. The total revenue for the [...]

By GoodWhale|August 13, 2023|Categories: Diagnostics & Research, Earnings Report, Intrinsic Value|Tags: $NASDAQ:ILMN, Diagnostics & Research, NASDAQ|0 Comments

Carl Icahn Bullish on Illumina Following CEO Transition
Gallery

Carl Icahn Bullish on Illumina Following CEO Transition

🌥️Trending News Carl Icahn is bullish on Illumina ($NASDAQ:ILMN) following CEO transition, as he believes the change will lead to [...]

By GoodWhale|June 17, 2023|Categories: Corporate Action, Diagnostics & Research|Tags: $NASDAQ:ILMN, Diagnostics & Research, NASDAQ|0 Comments

Market Underestimating Illumina’s Stock and Genomics Leadership
Gallery

Market Underestimating Illumina’s Stock and Genomics Leadership

🌥️Trending News Illumina ($NASDAQ:ILMN) is a world leader in genomics, offering a comprehensive range of products and services that revolutionize [...]